Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple Myeloma

NCT00813150 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Dexamethasone
DRUG: Bortezomib
DRUG: Cyclophosphamide

Sponsor

Janssen-Cilag G.m.b.H